A prospective trial of structured treatment interruptions in human immunodeficiency virus infection.
BACKGROUND: According to the "autovaccination hypothesis," reexposure to human immunodeficiency virus (HIV) during treatment interruptions may stimulate the HIV-specific immune response and lead to low viremia after withdrawal of highly active antiretroviral treatment (HAART). Many patien...
Autores principales: | Fagard, C, Oxenius, A, Günthard, H, Garcia, F, Le Braz, M, Mestre, G, Battegay, M, Furrer, H, Vernazza, P, Bernasconi, E, Telenti, A, Weber, R, Leduc, D, Yerly, S, Price, D, Dawson, S, Klimkait, T, Perneger, T, McLean, A, Clotet, B, Gatell, J, Perrin, L, Plana, M, Phillips, R, Hirschel, B |
---|---|
Formato: | Journal article |
Lenguaje: | English |
Publicado: |
2003
|
Ejemplares similares
-
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.
por: Oxenius, A, et al.
Publicado: (2002) -
Human immunodeficiency virus-specific T lymphocyte cell
por: Oxenius, A, et al.
Publicado: (2001) -
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.
por: Wolbers, M, et al.
Publicado: (2007) -
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3.
por: Plana, M, et al.
Publicado: (2004) -
Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions.
por: Joos, B, et al.
Publicado: (2005)